Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Esconet
Quarter-by-quarter operating performance
Financials of Esconet
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|
| Sales + | 44 | 69 | 95 | 137 | 225 | 263 |
| Expenses + | 44 | 67 | 89 | 128 | 217 | 256 |
| Operating Profit | 0 | 2 | 6 | 10 | 8 | 6 |
| OPM % | 0% | 3% | 6% | 7% | 3% | 2% |
| Other Income + | -0 | -0 | 0 | 0 | 3 | 4 |
| Interest | 1 | 1 | 1 | 2 | 1 | 1 |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | -1 | 1 | 4 | 7 | 9 | 8 |
| Tax % | -4% | -20% | 32% | 27% | 25% | |
| Net Profit + | -1 | 1 | 3 | 5 | 7 | 6 |
| EPS in Rs | -13.04 | 9.39 | 39.50 | 4.29 | 5.26 | 4.71 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Financials of Esconet
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.77 | 0.77 | 0.77 | 12 | 13 | 13 |
| Reserves | 1 | 2 | 5 | 24 | 56 | 61 |
| Borrowings + | 6 | 8 | 11 | 5 | 1 | 24 |
| Other Liabilities + | 9 | 16 | 12 | 33 | 46 | 65 |
| Total Liabilities | 17 | 26 | 29 | 75 | 115 | 164 |
| Fixed Assets + | 1 | 2 | 2 | 1 | 2 | 3 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 5 | 0 |
| Other Assets + | 16 | 24 | 27 | 73 | 108 | 161 |
| Total Assets | 17 | 26 | 29 | 75 | 115 | 164 |
Financials of Esconet
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | -0 | 1 | -2 | -2 | 0 |
| Cash from Investing Activity + | -1 | -1 | -0 | -1 | -5 |
| Cash from Financing Activity + | -2 | 1 | 2 | 18 | 20 |
| Net Cash Flow | -3 | -0 | 0 | 16 | 15 |
| Free Cash Flow | -1 | -1 | -2 | -2 | -1 |
| CFO/OP | -331% | 78% | -9% | 1% | 30% |
Financials of Esconet
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 72 | 82 | 49 | 102 | 87 |
| Inventory Days | 58 | 38 | 43 | 47 | 36 |
| Days Payable | 87 | 94 | 50 | 96 | 78 |
| Cash Conversion Cycle | 43 | 26 | 41 | 53 | 44 |
| Working Capital Days | 30 | 23 | 25 | 56 | 50 |
| ROCE % | 15% | 40% | 31% | 18% |
Overall long-term volume growth is guided around 8% to 10% Y-o-Y aligned with GDP growth, economy, digitalization, and low PC penetration. Key concall…
. Key concall takeaways from DC Infotech & Communication Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.
Track & Trace market could expand significantly if government mandates extend from top 300 to top 1,000 pharmaceutical brands, growing from ~₹600 crores to…
Growth drivers include price increases (~30-35%), new products/brands (5-10%), and volume increases (20-25%) with ~10% market share gain. Key concall takeaways…